About CR&T
Who We Are
In 1968, Richard T. Silver, MD, a prominent hematologist-oncologist, founded the Cancer Research & Treatment Fund (CR&T) with the belief that investing in blood cancer research would lead to important breakthroughs, as well as a better understanding of the biology and treatment of all forms of cancer. While the focus of the organization is the myeloproliferative neoplasms (MPNs), over the course of its 55-year history, CR&T has awarded more than $17 million in grants to research that has contributed to major advances in the fight against cancer.
Our Impact
BLOOD CANCER
RESEARCH
THE DR. RICHARD
T. SILVER CHAIR
FOR OTHER
CANCER RESEARCH














Medical Advisory Board
At CR&T, our activities and funding objectives are guided by the expertise of a world-class Medical Advisory Board, featuring some of the world’s foremost physician-scientists in cancer treatment research.
Your gift today can help change a cancer patient's life.
